Stockwatch: Batsu Games − Drug And Vaccine Development
Investors New To Biotech Are Just Learning That Failure Has Penalties
Executive Summary
Batsu is the Japanese term for games that have penalties, unlike those which are just for fun. Seasoned investors are well aware of the risks of drug and vaccine development but many investors new to the sector are just learning of the downsides.
You may also be interested in...
Ironwood Ends Phase III GERD Program, Will Cut 100 Jobs
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
Stockwatch: Pandemic And Biosimilar Effects Subordinate Early Third-Quarter Earnings Results
Early in 2020, company guidance was that pandemic-related effects would have dissipated in the third quarter. Issues specific to J&J and Roche leave this broad conclusion still up in the air.
Stockwatch: Some Failed Drugs Never Die, They Just Find New Investors
Drugs that have failed in clinical studies often come back for another go, making the same mistakes for a new cohort of investors who missed the first failure. The global pandemic is also enabling this for once- or twice-failed drugs.
Need a specific report? 1000+ reports available
Buy Reports